Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Abstracts: AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer; January 4-7, 2017; San Diego, CA

Chemical Biology

      • Chemical Biology: Oral Presentations - Invited Abstracts
      • Chemical Biology: Oral Presentations - Proffered Abstracts
      • Chemical Biology: Poster Presentations - Proffered Abstracts

Finding Synthetic Lethal Interactions through Functional Genomics

      • Finding Synthetic Lethal Interactions through Functional Genomics: Oral Presentations - Invited Abstracts
      • Finding Synthetic Lethal Interactions through Functional Genomics: Oral Presentations - Proffered Abstracts
      • Finding Synthetic Lethal Interactions through Functional Genomics: Poster Presentations - Proffered Abstracts

Model Organisms to Identify Synthetic Lethal Interactions

      • Model Organisms to Identify Synthetic Lethal Interactions: Oral Presentations - Invited Abstracts
      • Model Organisms to Identify Synthetic Lethal Interactions: Oral Presentations - Proffered Abstracts
      • Model Organisms to Identify Synthetic Lethal Interactions: Poster Presentations - Proffered Abstracts

New Technology and Bioinformatics

      • New Technology and Bioinformatics: Oral Presentations - Invited Abstracts
      • New Technology and Bioinformatics: Oral Presentations - Proffered Abstracts
      • New Technology and Bioinformatics: Poster Presentations - Proffered Abstracts

Resistance against Drug Combinations

      • Resistance against Drug Combinations: Oral Presentations - Invited Abstracts
      • Resistance against Drug Combinations: Oral Presentations - Proffered Abstracts
      • Resistance Against Drug Combinations: Poster Presentations - Proffered Abstracts

Other Topics

      • Other Topics: Oral Presentations - Proffered Abstracts
Back to top
PreviousNext
Molecular Cancer Therapeutics: 16 (10 Supplement)
October 2017
Volume 16, Issue 10 Supplement
  • Table of Contents

Sign up for alerts

Jump to

  • Chemical Biology
  • Finding Synthetic Lethal Interactions through Functional Genomics
  • Model Organisms to Identify Synthetic Lethal Interactions
  • New Technology and Bioinformatics
  • Resistance against Drug Combinations
  • Other Topics
Advertisement
  • Most Cited
  • Most Read
Loading
  • Anti-KIT DNA Aptamer Labeling in GIST
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Tipifarnib as a Precision Therapy for HRAS-Mutant HNSCC
  • Targeted Delivery of MMAE Using Bicycle Molecules
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement